GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OraSure Technologies Inc (FRA:EP3) » Definitions » Other Operating Expense

OraSure Technologies (FRA:EP3) Other Operating Expense : €0.0 Mil (TTM As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is OraSure Technologies Other Operating Expense?

OraSure Technologies's Other Operating Expense for the three months ended in Jun. 2024 was €0.0 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 was €0.0 Mil.

OraSure Technologies's quarterly Other Operating Expense declined from Dec. 2023 (€0.0 Mil) to Mar. 2024 (€0.0 Mil) and declined from Mar. 2024 (€0.0 Mil) to Jun. 2024 (€0.0 Mil).

OraSure Technologies's annual Other Operating Expense declined from Dec. 2021 (€0.0 Mil) to Dec. 2022 (€-0.0 Mil) and declined from Dec. 2022 (€-0.0 Mil) to Dec. 2023 (€-0.0 Mil).


OraSure Technologies Other Operating Expense Historical Data

The historical data trend for OraSure Technologies's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OraSure Technologies Other Operating Expense Chart

OraSure Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

OraSure Technologies Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

OraSure Technologies Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OraSure Technologies Other Operating Expense Related Terms

Thank you for viewing the detailed overview of OraSure Technologies's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


OraSure Technologies Business Description

Traded in Other Exchanges
Address
220 East First Street, Bethlehem, PA, USA, 18015
OraSure Technologies is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets most of its sales from the molecular solutions business, derived mainly from customers in the United States.

OraSure Technologies Headlines

No Headlines